PMID: 9555795Apr 29, 1998Paper

Low-dose low-molecular-weight heparin (enoxaparin) is beneficial in lichen planus: a preliminary report

Journal of the American Academy of Dermatology
E HodakI R Cohen

Abstract

Low-dose heparin devoid of anticoagulant activity inhibits T-lymphocyte heparanase activity, which is crucial in T-cell migration to target tissues. The purpose of this study was to assess the efficacy of low-dose enoxaparin (Clexane), a low-molecular-weight heparin, as monotherapy in lichen planus. Included in the study were 10 patients with widespread histopathologically proven lichen planus (LP) associated with intense pruritus of several months' duration. Patients were given 3 mg enoxaparin, subcutaneously once weekly; three patients received four injections, and seven patients received six injections. In nine patients the itch disappeared within 2 weeks. Within 4 to 10 weeks in eight of these patients, there was complete regression of the eruption with residual postinflammatory hyperpigmentation; in one patient, there was marked improvement. In one patient, no effect was observed. Of the four patients who also had oral LP, only one showed improvement. No side effects were observed in any of the patients. These findings indicate that enoxaparin may be a simple, effective treatment for cutaneous LP.

References

Jul 1, 1992·The British Journal of Dermatology·N J LevellJ M Marks
Jan 1, 1990·The British Journal of Dermatology·P D PigattoA F Finzi
Oct 1, 1989·Oral Surgery, Oral Medicine, and Oral Pathology·R A StraussK Soltani
Jan 1, 1968·Oral Surgery, Oral Medicine, and Oral Pathology·J O Andreasen
May 23, 1995·Proceedings of the National Academy of Sciences of the United States of America·O LiderI R Cohen
Jun 1, 1993·The American Journal of Dermatopathology·R AkasuH J Kahn
Aug 26, 1993·The New England Journal of Medicine·D E ConwillV E Herrin

❮ Previous
Next ❯

Citations

Feb 11, 2005·Microsurgery·Nilgün Markal ErtaşMaria Siemionow
Jan 17, 2004·Journal of the American Academy of Dermatology·Gregory DePriscoTorsten Ehrig
Jan 8, 2000·Dermatologic Clinics·A S Boyd
Nov 19, 2002·Clinics in Dermatology·Ronni WolfBinnur Tüzün
May 16, 2000·International Journal of Dermatology·V N Sehgal, S Jain
Oct 21, 2005·International Journal of Clinical Practice·S AkdenizM Yaldiz
Dec 5, 2003·Journal of Periodontology
Nov 13, 2001·American Journal of Clinical Dermatology·C ScullyM Carrozzo
Aug 23, 2008·American Journal of Clinical Dermatology·Evangelos CholongitasDespina Ioannidou
Jan 12, 2011·Indian Journal of Dermatology, Venereology and Leprology·Sirin YasarPembegul Gunes
Aug 27, 2015·Expert Review of Clinical Pharmacology·Qi Ying LeanRahul P Patel
Oct 29, 2015·American Journal of Clinical Dermatology·Lihi AtzmonyDaniel Mimouni
Jan 31, 2008·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Lida RadfarLakshmanan Suresh
Sep 8, 2007·The British Journal of Oral & Maxillofacial Surgery·Crispian Scully, Marco Carrozzo
Aug 3, 2013·The Australasian Journal of Dermatology·Kazutoshi Murao, Yoshiaki Kubo
Jul 2, 2003·Journal of the European Academy of Dermatology and Venereology : JEADV·R Ruiz VillaverdeR Naranjo Sintes
Jan 7, 2014·Expert Opinion on Investigational Drugs·Madhur D ShastriRahul P Patel
Aug 2, 2007·Expert Opinion on Therapeutic Targets·Ralf J LudwigWolf-Henning Boehncke
Jun 2, 2000·Seminars in Dialysis·I F Schwartz, A Iaina
Jan 8, 2000·Dermatologic Clinics·J L Popovsky, C Camisa
Dec 22, 1999·The British Journal of Dermatology·M P StefanidouA D Tosca
Dec 7, 2013·Integrative Biology : Quantitative Biosciences From Nano to Macro·Qi Ying LeanNuri Gueven
Apr 27, 2010·Dermatologic Therapy·Carmen Sălăvăstru, George-Sorin Tiplica
Nov 5, 2005·Oral Diseases·D EisenK Thongprasom
Jul 3, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·H Husein-ElAhmedM Steinhoff
Jun 18, 2002·The Journal of Pharmacology and Experimental Therapeutics·Kent W ChristophersonRobert A Hromas
Apr 9, 2015·American Journal of Therapeutics·Berna Solak
Sep 14, 1999·Oral Diseases·M Carrozzo, S Gandolfo
Aug 28, 2003·Journal of the European Academy of Dermatology and Venereology : JEADV·R Ruiz VillaverdeS Serrano Ortega
Aug 28, 2003·Journal of the European Academy of Dermatology and Venereology : JEADV·A FerahbasO Kontas
Jun 21, 2018·Frontiers in Pharmacology·Rahul P PatelGregory M Peterson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.